Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1046 per EA under NDC 72888006305. Its NADAC has been published 156 times since Aug 30, 2023.
FDA first approved this application on Apr 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888006305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075521FDA Approved
4/5/2002
TE Code
AB
On Market Since
3/16/2021
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 156 times since Aug 30, 2023, and over the history we have for it it has declined 35.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1046 per EA |
|---|---|
| All-time high | $0.1623 (Sep 13, 2023) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1212 |
| 52-week low | $0.1046 |
| Median price | $0.1189 |
| Average price | $0.1200 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 156 |
| Tracking since | Aug 30, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1046 per EA (NDC 72888006305), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 35.6%. It has been tracked across 156 weekly CMS publications since Aug 30, 2023.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Aug 30, 2023, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.1623 (Sep 13, 2023), with a median of $0.1189 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 72888006305) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.